drugset / Trial / NCT07385755
Desvenlafaxine for Preventive Treatment of Frequent Migraines
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate whether Desvenlafaxine can reduce the frequency and severity of migraine attacks in patients.
Timeline
- Start
- 2026-01-01
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | — | — |